Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Xenon Pharmaceuticals Inc
(NQ:
XENE
)
38.37
-0.09 (-0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenon Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
October 04, 2021
Xenon Pharmaceuticals Inc (NASDAQ: XENE) has reported topline results from the Phase 2b X-TOLE trial evaluating XEN1101 as an adjunctive treatment in adult...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Factory Orders Surpass Estimates
October 04, 2021
Following the market opening Monday, the Dow traded down 0.01% to 34,326.18 while the NASDAQ fell 1.4% to 14,362.69. The S&P also fell, dropping 0.51% to 4,334.77. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Xenon Pharmaceuticals Stock Is Soaring Today
October 04, 2021
Xenon Pharmaceuticals Inc (NASDAQ: XENE) is trading significantly higher Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all...
Via
Benzinga
Why Xenon Pharmaceuticals Stock Is Screaming Higher Today
October 04, 2021
A positive mid-stage trial is powering this biotech stock higher today.
Via
The Motley Fool
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
September 28, 2021
Benzinga Pro data, Xenon Pharmaceuticals (NASDAQ:XENE) reported Q2 sales of $2.22 million. Earnings fell to a loss of $22.50 million, resulting in a 40.1% decrease from last...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 11, 2021
May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 11, 2021
August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...
Via
Benzinga
18 Key Biopharma Catalysts To Keep An Eye On In Q3
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the...
Via
Talk Markets
18 Key Biopharma Catalysts To Keep An Eye On In Q3
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...
Via
Benzinga
Return On Capital Employed Overview: Xenon Pharmaceuticals
June 18, 2021
In Q1, Xenon Pharmaceuticals (NASDAQ:XENE) posted sales of $4.36 million. Earnings were up 24.27%, but Xenon Pharmaceuticals still reported an overall loss of $16.06 million. In...
Via
Benzinga
Looking Into Xenon Pharmaceuticals's Return On Capital Employed
June 04, 2021
During Q1, Xenon Pharmaceuticals's (NASDAQ:XENE) reported sales totaled $4.36 million. Despite a 24.27% in earnings, the company posted a loss of $16.06 million. In Q4, Xenon...
Via
Benzinga
Xenon Pharmaceuticals's Earnings Outlook
May 10, 2021
Xenon Pharmaceuticals (NASDAQ:XENE) announces its next round of earnings this Tuesday, May 11. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.